CHLOE GAINES: Open Payments
NPI 1073053781 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 28 payments from 13 companies in 2025. Trend: 2023 $258 · 2024 $771 · 2025 $632
Food & beverage: $566Education: $66
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 6 | $103 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| SANOFI-AVENTIS U.S. LLC | 1 | $66 |
| GENZYME CORPORATION | 2 | $57 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| HARMONY BIOSCIENCES LLC | 2 | $45 |
| ABBVIE INC. | 2 | $44 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $33 |
Products named: DUPIXENT, Ohtuvayre, Sunosi, NUCALA, WAKIX, LINZESS, ZEPBOUND, INSPIRE.
Industry payments across MD — which companies pay providers there.
